Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 8/2018

01-08-2018 | Review

How Should We Report Endoscopic Results in Patient’s with Barrett’s Esophagus?

Authors: Venkata Subhash Gorrepati, Prateek Sharma

Published in: Digestive Diseases and Sciences | Issue 8/2018

Login to get access

Abstract

Barrett’s esophagus is the only known pre-cancerous lesion for esophageal adenocarcinoma and is diagnosed by high-definition white light endoscopy demonstrating a columnar-lined esophagus along with biopsy evidence of intestinal metaplasia. With accurate performance and reporting of the endoscopic procedure, an evidence-based management strategy can be developed for treatment of Barrett’s dysplasia. However, cross-sectional data demonstrate that there is still inconsistency among gastroenterologists in performance and reporting of endoscopic findings in patients with Barrett’s esophagus. Here, we present an evidence-based review of how to report endoscopic findings in Barrett’s esophagus.
Literature
1.
2.
Shaheen NJ, Falk GW, Iyer PG, Gerson LB. ACG clinical guideline: diagnosis and management of Barrett’s esophagus. Am J Gastroenterol. 2016;111:30–50. (quiz 51).CrossRefPubMed
3.
Skinner DB, Walther BC, Riddell RH, Schmidt HE, Lascone C, Demeester TR. Barrett’s esophagus. Comparison of benign and malignant cases. Ann Surg. 1983;198:554–565.CrossRefPubMedPubMedCentral
4.
Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK, et al. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet. 1994;344:1533–1536.CrossRefPubMed
5.
Jung KW, Talley NJ, Romero Y, et al. Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett’s esophagus: a population-based study. Am J Gastroenterol. 2011;106:1447–1455. (quiz 1456).CrossRefPubMedPubMedCentral
6.
Sikkema M, Looman CW, Steyerberg EW, et al. Predictors for neoplastic progression in patients with Barrett’s esophagus: a prospective cohort study. Am J Gastroenterol. 2011;106:1231–1238.CrossRefPubMed
7.
Coleman HG, Bhat SK, Murray LJ, et al. Symptoms and endoscopic features at Barrett’s esophagus diagnosis: implications for neoplastic progression risk. Am J Gastroenterol. 2014;109:527–534.CrossRefPubMed
8.
Buttar NS, Wang KK, Sebo TJ, et al. Extent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma. Gastroenterology. 2001;120:1630–1639.CrossRefPubMed
9.
Montgomery E, Bronner MP, Greenson JK, et al. Are ulcers a marker for invasive carcinoma in Barrett’s esophagus? Data from a diagnostic variability study with clinical follow-up. Am J Gastroenterol. 2002;97:27–31.CrossRefPubMed
10.
Peters FP, Brakenhoff KP, Curvers WL, et al. Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett’s esophagus. Gastrointest Endosc. 2008;67:604–609.CrossRefPubMed
11.
Tharavej C, Hagen JA, Peters JH, et al. Predictive factors of coexisting cancer in Barrett’s high-grade dysplasia. Surg Endosc. 2006;20:439–443.CrossRefPubMed
12.
Sharma N, Srivastava S, Kern F, et al. Endoscopic modalities for the diagnosis of Barrett’s oesophagus. United European Gastroenterol J. 2016;4:733–740.CrossRefPubMed
13.
Brown J, Sharma P. From Prague to Seattle: improved endoscopic technique and reporting improves outcomes in patients with Barrett’s esophagus. Dig Dis Sci. 2016;61:4–5.CrossRefPubMed
14.
Visrodia K, Iyer PG, Schleck CD, et al. Yield of repeat endoscopy in Barrett’s esophagus with no dysplasia and low-grade dysplasia: a population-based study. Dig Dis Sci. 2016;61:158–167.CrossRefPubMed
15.
Singh M, Gupta N, Gaddam S, et al. Practice patterns among U.S. gastroenterologists regarding endoscopic management of Barrett’s esophagus. Gastrointest Endosc. 2013;78:689–695.CrossRefPubMed
16.
Kwon RS, Adler DG, Chand B, et al. High-resolution and high-magnification endoscopes. Gastrointest Endosc. 2009;69:399–407.CrossRefPubMed
17.
Canto MI, Anandasabapathy S, Brugge W, et al. In vivo endomicroscopy improves detection of Barrett’s esophagus-related neoplasia: a multicenter international randomized controlled trial (with video). Gastrointest Endosc. 2014;79:211–221.CrossRefPubMed
18.
Sharma P, Hawes RH, Bansal A, et al. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett’s oesophagus: a prospective, international, randomised controlled trial. Gut. 2013;62:15–21.CrossRefPubMed
19.
Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63:7–42.CrossRefPubMed
20.
Spechler SJ, Sharma P, Souza RF, et al. American Gastroenterological Association technical review on the management of Barrett’s esophagus. Gastroenterology. 2011;140:e18-52. (quiz e13).CrossRef
21.
Boyce HW. Endoscopic definitions of esophagogastric junction regional anatomy. Gastrointest Endosc. 2000;51:586–592.CrossRefPubMed
22.
23.
American Gastroenterological Association. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140:1084–1091.CrossRef
24.
Wallner B. Endoscopically defined gastroesophageal junction coincides with the anatomical gastroesophageal junction. Surg Endosc. 2009;23:2155–2158.CrossRefPubMed
25.
Ogiya K, Kawano T, Ito E, et al. Lower esophageal palisade vessels and the definition of Barrett’s esophagus. Dis Esophagus. 2008;21:645–649.CrossRefPubMed
26.
Andrici J, Tio M, Cox MR, et al. Hiatal hernia and the risk of Barrett’s esophagus. J Gastroenterol Hepatol. 2013;28:415–431.CrossRefPubMed
27.
Johnson DA, Younes Z, Hogan WJ. Endoscopic assessment of hiatal hernia repair. Gastrointest Endosc. 2000;52:650–659.CrossRefPubMed
28.
29.
Weusten B, Bisschops R, Coron E, et al. Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy. 2017;49:191–198.CrossRefPubMed
30.
Gopal DV, Lieberman DA, Magaret N, et al. Risk factors for dysplasia in patients with Barrett’s esophagus (BE): results from a multicenter consortium. Dig Dis Sci. 2003;48:1537–1541.CrossRefPubMed
31.
Menke-Pluymers MB, Hop WC, Dees J, et al. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer. 1993;72:1155–1158.CrossRefPubMed
32.
Anaparthy R, Gaddam S, Kanakadandi V, et al. Association between length of Barrett’s esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia. Clin Gastroenterol Hepatol. 2013;11:1430–1436.CrossRefPubMed
33.
Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE. Dysplasia in short-segment Barrett’s esophagus: a prospective 3-year follow-up. Am J Gastroenterol. 1997;92:2012–2016.PubMed
34.
Weston AP, Krmpotich PT, Cherian R, Dixon A, Topalosvki M. Prospective long-term endoscopic and histological follow-up of short segment Barrett’s esophagus: comparison with traditional long segment Barrett’s esophagus. Am J Gastroenterol. 1997;92:407–413.PubMed
35.
Conio M, Aste H, Bonelli L. “Short” Barrett’s esophagus: a condition not to be underestimated. Gastrointest Endosc. 1994;40:111.CrossRefPubMed
36.
Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131:1392–1399.CrossRefPubMed
37.
Alvarez Herrero L, Curvers WL, Van Vilsteren FG, et al. Validation of the Prague C&M classification of Barrett’s esophagus in clinical practice. Endoscopy. 2013;45:876–882.CrossRefPubMed
38.
Vahabzadeh B, Seetharam AB, Cook MB, et al. Validation of the Prague C & M criteria for the endoscopic grading of Barrett’s esophagus by gastroenterology trainees: a multicenter study. Gastrointest Endosc. 2012;75:236–241.CrossRefPubMedPubMedCentral
39.
Chang CY, Lee YC, Lee CT, et al. The application of Prague C and M criteria in the diagnosis of Barrett’s esophagus in an ethnic Chinese population. Am J Gastroenterol. 2009;104:13–20.CrossRefPubMed
40.
Lee YC, Cook MB, Bhatia S, et al. Interobserver reliability in the endoscopic diagnosis and grading of Barrett’s esophagus: an Asian multi-national study. Endoscopy. 2010;42:699–704.CrossRefPubMedPubMedCentral
41.
Gupta N, Gaddam S, Wani SB, et al. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett’s esophagus. Gastrointest Endosc. 2012;76:531–538.CrossRefPubMed
42.
Bisschops R, Areia M, Coron E, et al. Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy quality improvement initiative. United European Gastroenterol J. 2016;4:629–656.CrossRefPubMedPubMedCentral
43.
Enestvedt BK, Lugo R, Guarner-Argente C, et al. Location, location, location: does early cancer in Barrett’s esophagus have a preference? Gastrointest Endosc. 2013;78:462–467.CrossRefPubMed
44.
Kariyawasam VC, Bourke MJ, Hourigan LF, et al. Circumferential location predicts the risk of high-grade dysplasia and early adenocarcinoma in short-segment Barrett’s esophagus. Gastrointest Endosc. 2012;75:938–944.CrossRefPubMed
45.
Cassani L, Sumner E, Slaughter JC, et al. Directional distribution of neoplasia in Barrett’s esophagus is not influenced by distance from the gastroesophageal junction. Gastrointest Endosc. 2013;77:877–882.CrossRefPubMed
46.
Axon A, Diebold MD, Fujino M, et al. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy. 2005;37:570–578.CrossRef
47.
Prasad GA, Bansal A, Sharma P, et al. Predictors of progression in Barrett’s esophagus: current knowledge and future directions. Am J Gastroenterol. 2010;105:1490–1502.CrossRefPubMedPubMedCentral
48.
Pech O, Gossner L, Manner H, et al. Prospective evaluation of the macroscopic types and location of early Barrett’s neoplasia in 380 lesions. Endoscopy. 2007;39:588–593.CrossRefPubMed
49.
Abela JE, Going JJ, Mackenzie JF, et al. Systematic four-quadrant biopsy detects Barrett’s dysplasia in more patients than nonsystematic biopsy. Am J Gastroenterol. 2008;103:850–855.CrossRefPubMed
50.
Levine DS, Blount PL, Rudolph RE, et al. Safety of a systematic endoscopic biopsy protocol in patients with Barrett’s esophagus. Am J Gastroenterol. 2000;95:1152–1157.CrossRefPubMed
51.
Boerwinkel DF, Swager AF, Curvers WL, Bergman JJ. The clinical consequences of advanced imaging techniques in Barrett’s esophagus. Gastroenterology. 2014;146:622–629.CrossRefPubMed
52.
Gill RS, Singh R. Endoscopic imaging in Barrett’s esophagus: current practice and future applications. Ann Gastroenterol. 2012;25:89–95.PubMedPubMedCentral
53.
Wolfsen HC, Sharma P, Wallace MB, et al. Safety and feasibility of volumetric laser endomicroscopy in patients with Barrett’s esophagus (with videos). Gastrointest Endosc. 2015;82:631–640.CrossRefPubMed
54.
ASGE Technology Committee, Dayyeh BK, Thosani N, et al. ASGE Technology Committee systematic review and meta-analysis assessing the ASGE Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for adopting real-time imaging-assisted endoscopic targeted biopsy during endoscopic surveillance of Barrett’s esophagus. Gastrointest Endosc. 2016;83:684–698.CrossRef
55.
Sharma P, Brill J, Canto M, et al. White paper AGA: advanced imaging in Barrett’s esophagus. Clin Gastroenterol Hepatol. 2015;13:2209–2218.CrossRefPubMed
56.
Chedgy FJQ, Subramaniam S, Kandiah K, et al. Acetic acid chromoendoscopy: improving neoplasia detection in Barrett’s esophagus. World J Gastroenterol. 2016;22:5753–5760.CrossRefPubMedPubMedCentral
57.
Reaud S, Croue A, Boyer J. Diagnostic accuracy of magnifying chromoendoscopy with detection of intestinal metaplasia and dysplasia using acetic acid in Barrett’s esophagus. Gastroenterol Clin Biol. 2006;30:217–223.CrossRefPubMed
58.
Mayinger B, Oezturk Y, Stolte M, et al. Evaluation of sensitivity and inter- and intra-observer variability in the detection of intestinal metaplasia and dysplasia in Barrett’s esophagus with enhanced magnification endoscopy. Scand J Gastroenterol. 2006;41:349–356.CrossRefPubMed
59.
Yagi K, Nakamura A, Sekine A, et al. Endoscopic diagnosis of mucosal adenocarcinomas and intestinal metaplasia of columnar-lined esophagus using enhanced-magnification endoscopy. Dig Endosc. 2006;18:S21–S26.CrossRef
60.
Fortun PJ, Anagnostopoulos GK, Kaye P, et al. Acetic acid-enhanced magnification endoscopy in the diagnosis of specialized intestinal metaplasia, dysplasia and early cancer in Barrett’s oesophagus. Aliment Pharmacol Ther. 2006;23:735–742.CrossRefPubMed
61.
Bhandari P, Kandaswamy P, Cowlishaw D, et al. Acetic acid-enhanced chromoendoscopy is more cost-effective than protocol-guided biopsies in a high-risk Barrett’s population. Dis Esophagus. 2012;25:386–392.CrossRefPubMed
62.
Longcroft–Wheaton G, Duku M, Mead R, et al. Acetic acid spray is an effective tool for the endoscopic detection of neoplasia in patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2010;8:843–847.CrossRefPubMed
63.
Pohl J, May A, Rabenstein T, et al. Comparison of computed virtual chromoendoscopy and conventional chromoendoscopy with acetic acid for detection of neoplasia in Barrett’s esophagus. Endoscopy. 2007;39:594–598.CrossRefPubMed
64.
Vazquez-Iglesias JL, Alonso-Aguirre P, Diz-Lois MT, et al. Acetic acid allows effective selection of areas for obtaining biopsy samples in Barrett’s esophagus. Eur J Gastroenterol Hepatol. 2007;19:187–193.CrossRefPubMed
65.
Pohl J, Pech O, May A, et al. Incidence of macroscopically occult neoplasias in Barrett’s esophagus: are random biopsies dispensable in the era of advanced endoscopic imaging? Am J Gastroenterol. 2010;105:2350–2356.CrossRefPubMed
66.
Coletta M, Sami SS, Nachiappan A, Fraquelli M, Casazza G, Ragunath K. Acetic acid chromoendoscopy for the diagnosis of early neoplasia and specialized intestinal metaplasia in Barrett’s esophagus: a meta-analysis. Gastrointest Endosc. 2016;83:57–67.CrossRefPubMed
67.
68.
Wani S, Sharma P. Narrow band imaging in Barrett’s esophagus. Expert Rev Gastroenterol Hepatol. 2007;1:53–60.CrossRefPubMed
69.
Wolfsen HC, Crook JE, Krishna M, et al. Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett’s Esophagus. Gastroenterology. 2008;135:24–31.CrossRefPubMed
70.
Sharma P, Bergman JJ, Goda K, et al. Development and validation of a classification system to identify high-grade dysplasia and esophageal adenocarcinoma in Barrett’s esophagus using narrow-band imaging. Gastroenterology. 2016;150:591–598.CrossRefPubMed
Metadata
Title
How Should We Report Endoscopic Results in Patient’s with Barrett’s Esophagus?
Authors
Venkata Subhash Gorrepati
Prateek Sharma
Publication date
01-08-2018
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2018
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5067-7

Other articles of this Issue 8/2018

Digestive Diseases and Sciences 8/2018 Go to the issue

Review

Clinical Guidelines Update on the Diagnosis and Management of Barrett’s Esophagus

Review

Barrett’s Esophagus and Esophageal Adenocarcinoma: How Common Are They Really?

Review

Natural History of Barrett’s Esophagus

Review

Origins of Metaplasia in Barrett’s Esophagus: Is this an Esophageal Stem or Progenitor Cell Disease?

Review

Is Barrett’s-Associated Esophageal Adenocarcinoma a Clonal Disease?

Review

Chemoprevention of Barrett’s Esophagus and Esophageal Adenocarcinoma

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits